| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
John C Bolger last filed a Form 4 in August 2022, as Director at FLGT. John C Bolger's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns John C Bolger a middling insider score of 65/100, based on 5 past trades. Over a 12-month horizon, all 5 of those trades were profitable, with an average 12-month return of +35.1%.
At the last filing, the largest reported position was 5,100 shares of FLGT. The FLGT filings lean toward selling, a net 26,172 shares.
John C Bolger has 16 Form 4 filings on record from September 2016 to August 2022, all as Director at Fulgent Genetics (FLGT), 2016–2022.
The 47 reported transactions were 17 option exercises, 15 open-market sales, 8 option or other derivative awards and 4 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 9 sales worth about $1.2M.
The largest open-market sale was 3,374 shares of FLGT at an average $101.62 on March 9, 2021, about $343K.
Shares as reported in the last Form 4 for each company; the most recent is from August 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2022 | FLGT Fulgent Genetics, Inc. | Director | Sale+OE | 1,126 | $55.32 | $62,291.38 | -24.3% | -17.8% | -27.0% | |
| Mar 1, 2022 | FLGT Fulgent Genetics, Inc. | Director | Sale+OE | 1,875 | $61.36 | $115,056.44 | -48.4% | -10.6% | -47.7% | |
| Aug 30, 2021 | FLGT Fulgent Genetics, Inc. | Director | Sale+OE | 936 | $91.29 | $85,449.50 | -31.9% | +6.2% | -51.7% | |
| Jun 3, 2021 | FLGT Fulgent Genetics, Inc. | Director | Sell | 125 | $74.17 | $9,271.25 | -5.9% | +29.6% | -26.7% | |
| Jun 1, 2021 | FLGT Fulgent Genetics, Inc. | Director | Sale+OE | 1,876 | $71.41 | $133,965.54 | -46.9% | +31.9% | -22.4% | |
| Mar 9, 2021 | FLGT Fulgent Genetics, Inc. | Director | Sale+OE | 3,374 | $101.62 | $342,882.08 | -96.4% | - | - | |
| Nov 17, 2020 | FLGT Fulgent Genetics, Inc. | Director | Sale+OE | 4,269 | $44.24 | $188,876.78 | -91.9% | - | - | |
| Aug 17, 2020 | FLGT Fulgent Genetics, Inc. | Director | Sale+OE | 3,914 | $40.87 | $159,967.14 | -66.0% | - | - | |
| May 22, 2020 | FLGT Fulgent Genetics, Inc. | Director | Sale+OE | 8,677 | $15.36 | $133,288.26 | -72.5% | - | - |